Literature DB >> 4022885

Ergotamine abuse and extra-hepatic portal hypertension.

P E Fisher, D B Silk, N Menzies-Gow, M Dingle.   

Abstract

Arterial complications following ergotamine therapy have been well recognized since the beginning of this century. Venous complications, however, have only rarely been reported. A 48 year old Nigerian woman developed extra-hepatic portal hypertension coincident with a chronic overdosage of ergotamine. The literature elucidating the possible mechanisms involved is reviewed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4022885      PMCID: PMC2418255          DOI: 10.1136/pgmj.61.715.461

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  25 in total

1.  Studies on the venoconstrictor effect of ergot compounds in man.

Authors:  W H Aellig
Journal:  Triangle       Date:  1975

2.  IMPENDING GANGRENE OF FOUR EXTREMITIES SECONDARY TO ERGOTISM.

Authors:  J J CRANLEY; R J KRAUSE; E S STRASSER; C D HAFNER
Journal:  N Engl J Med       Date:  1963-10-03       Impact factor: 91.245

3.  Ergot alkaloids: hepatic distribution and estimation of absorption by measurement of total radioactivity in bile and urine.

Authors:  F Nimmerfall; J Rosenthaler
Journal:  J Pharmacokinet Biopharm       Date:  1976-02

4.  Ergotamine-induced venous thrombosis.

Authors:  U Mintz; S Bar-Meir; A De Vries
Journal:  Postgrad Med J       Date:  1974-04       Impact factor: 2.401

5.  Studies on the peripheral mode of action of dihydroergotamine in human and canine veins.

Authors:  E Müller-Schweinitzer
Journal:  Eur J Pharmacol       Date:  1974-07       Impact factor: 4.432

6.  Ergotamine poisoning producing renal arterial spasm.

Authors:  M S Fedotin; C Hartman
Journal:  N Engl J Med       Date:  1970-09-03       Impact factor: 91.245

7.  Angiography in peripheral ischaemia due to ergotism. Report of two cases.

Authors:  D Sutton; B J Preston
Journal:  Br J Radiol       Date:  1970-11       Impact factor: 3.039

8.  Ergot poisoning.

Authors:  G Glazer; K A Myers; E R Davies
Journal:  Postgrad Med J       Date:  1966-09       Impact factor: 2.401

9.  Enhanced prostaglandin synthesis contributes to the venoconstrictor activity of ergotamine.

Authors:  E Müller-Schweinitzer; J Brundell
Journal:  Blood Vessels       Date:  1975

10.  Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog.

Authors:  E Müller-Schweinitzer; E Stürmer
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

View more
  1 in total

1.  Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).

Authors:  Manfred Hauben; Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.